niacinamide has been researched along with Libman-Sacks Disease in 8 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Activation of B cells is a hallmark of systemic lupus erythematosus (SLE)." | 1.42 | Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus. ( Akashi, K; Iwata, S; Jabbarzadeh-Tabrizi, S; Kondo, M; Niiro, H; Tanaka, Y; Wang, SP; Yamaoka, K; Yoshikawa, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 1 |
| Singh, K | 1 |
| Lin, A | 1 |
| Meadows, AM | 1 |
| Wu, K | 1 |
| Shing, V | 1 |
| Bley, M | 1 |
| Hassanzadeh, S | 1 |
| Huffstutler, RD | 1 |
| Schmidt, MS | 1 |
| Blanco, LP | 1 |
| Tian, R | 1 |
| Brenner, C | 1 |
| Pirooznia, M | 1 |
| Kaplan, MJ | 1 |
| Sack, MN | 1 |
| Imaruoka, K | 1 |
| Oe, Y | 1 |
| Fushima, T | 1 |
| Sato, E | 1 |
| Sekimoto, A | 1 |
| Sato, H | 1 |
| Sugawara, J | 1 |
| Ito, S | 1 |
| Takahashi, N | 1 |
| Iwata, S | 1 |
| Yamaoka, K | 1 |
| Niiro, H | 1 |
| Jabbarzadeh-Tabrizi, S | 1 |
| Wang, SP | 1 |
| Kondo, M | 1 |
| Yoshikawa, M | 1 |
| Akashi, K | 1 |
| Tanaka, Y | 1 |
| Tutrone, WD | 1 |
| Spann, CT | 1 |
| Scheinfeld, N | 1 |
| Deleo, VA | 1 |
| RUGGIERO, N | 1 |
| BETTLEY, FR | 1 |
| Takeuchi, F | 1 |
| Otsuka, F | 1 |
| Enomoto, T | 1 |
| Hanaoka, F | 1 |
| Yamada, M | 1 |
| Kamatani, N | 1 |
| Nakano, K | 1 |
| Matsuta, K | 1 |
| Tanimoto, K | 1 |
| Morita, T | 1 |
| Goldstein, BD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study to Evaluate the Effect of Nicotinamide Riboside on Immunity[NCT02812238] | 38 participants (Actual) | Interventional | 2016-06-23 | Completed | |||
| Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE)[NCT00001372] | 2,250 participants (Anticipated) | Observational | 1994-02-10 | Recruiting | |||
| Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use[NCT00001846] | 5,000 participants (Anticipated) | Observational | 2001-01-11 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The IL- 1beta secretion is measured in response to fasting, refeeding and administration of Nicotinamide Riboside (or placebo). Nicotinamide riboside acts as a fasting mimetic, and is supposed to maintain the reduction of IL-1 beta secretion (indicating NLRP3 inflammasome activation) induced by fasting. 1000 mg of Nicotinamide riboside on a daily basis is given to the subjects for a period of 7-10 days. (NCT02812238)
Timeframe: 4 weeks
| Intervention | mg/dL (Mean) |
|---|---|
| Nicotinamide Riboside | 582 |
| Placebo | 794 |
1 review available for niacinamide and Libman-Sacks Disease
| Article | Year |
|---|---|
Polymorphic light eruption.
Topics: Arachidonic Acid; Comorbidity; Dermatologic Agents; Humans; Hydroxychloroquine; Lupus Erythematosus, | 2003 |
7 other studies available for niacinamide and Libman-Sacks Disease
| Article | Year |
|---|---|
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Topics: Clinical Studies as Topic; Humans; Inosine; Interferon-beta; Lipopolysaccharides; Lupus Erythematosu | 2022 |
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Topics: Clinical Studies as Topic; Humans; Inosine; Interferon-beta; Lipopolysaccharides; Lupus Erythematosu | 2022 |
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Topics: Clinical Studies as Topic; Humans; Inosine; Interferon-beta; Lipopolysaccharides; Lupus Erythematosu | 2022 |
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Topics: Clinical Studies as Topic; Humans; Inosine; Interferon-beta; Lipopolysaccharides; Lupus Erythematosu | 2022 |
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Topics: Clinical Studies as Topic; Humans; Inosine; Interferon-beta; Lipopolysaccharides; Lupus Erythematosu | 2022 |
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Topics: Clinical Studies as Topic; Humans; Inosine; Interferon-beta; Lipopolysaccharides; Lupus Erythematosu | 2022 |
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Topics: Clinical Studies as Topic; Humans; Inosine; Interferon-beta; Lipopolysaccharides; Lupus Erythematosu | 2022 |
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Topics: Clinical Studies as Topic; Humans; Inosine; Interferon-beta; Lipopolysaccharides; Lupus Erythematosu | 2022 |
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Topics: Clinical Studies as Topic; Humans; Inosine; Interferon-beta; Lipopolysaccharides; Lupus Erythematosu | 2022 |
Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide.
Topics: Animals; Disease Models, Animal; Female; Glomerulonephritis; Lipopolysaccharides; Lupus Erythematosu | 2019 |
Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
Topics: Adolescent; Adult; Antigens, CD19; B-Lymphocytes; Case-Control Studies; Female; Flow Cytometry; Huma | 2015 |
[Filatov tissue implants and nicotinic acid amide in lupus erythematosus].
Topics: Amides; Cell- and Tissue-Based Therapy; Lupus Erythematosus, Systemic; Niacin; Niacinamide; Nicotini | 1953 |
CHILBLAIN LUPUS ERYTHEMATOSUS.
Topics: Chilblains; Chloroquine; Fluocinolone Acetonide; Frostbite; Humans; Hydroxychloroquine; Hypothyroidi | 1964 |
Decrease in the reaction of DNA repair synthesis in response to nicotinamide or 3-aminobenzamide in ultraviolet irradiated systemic lupus erythematosus lymphocytes.
Topics: Benzamides; DNA Repair; Humans; In Vitro Techniques; Lupus Erythematosus, Systemic; Lymphocytes; Nia | 1985 |
Exacerbation of dapsone-induced Heinz body hemolytic anemia following treatment with methylene blue.
Topics: Anemia, Hemolytic; Dapsone; Erythrocytes; Female; Glutathione; Heinz Bodies; Humans; Lupus Erythemat | 1974 |